Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals.
Alamer A, Almutairi AR, Halloush S, Al-Jedai A, Alrashed A, AlFaifi M, Mohzari Y, Almutairi M, AlHassar F, Howaidi J, Almutairi W, Abraham I, Alkhatib N. Alamer A, et al. Among authors: alfaifi m. Saudi Pharm J. 2023 Apr;31(4):510-516. doi: 10.1016/j.jsps.2023.02.003. Epub 2023 Feb 15. Saudi Pharm J. 2023. PMID: 36819111 Free PMC article.
Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis.
Alamer A, Alrashed AA, Alfaifi M, Alosaimi B, AlHassar F, Almutairi M, Howaidi J, Almutairi W, Mohzari Y, Sulaiman T, Al-Jedai A, Alajami HN, Alkharji F, Alsaeed A, Alali AH, Baredhwan AA, Abraham I, Almulhim AS. Alamer A, et al. Among authors: alfaifi m. Curr Med Res Opin. 2021 Jul;37(7):1085-1097. doi: 10.1080/03007995.2021.1920900. Epub 2021 May 19. Curr Med Res Opin. 2021. PMID: 33890544 Free PMC article.
A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data.
Alrashed A, Cahusac P, Mohzari YA, Bamogaddam RF, Alfaifi M, Mathew M, Alrumayyan BF, Alqahtani BF, Alshammari A, AlNekhilan K, Binrokan A, Alamri K, Alshahrani A, Alshahrani S, Alanazi AS, Alhassan BM, Alsaeed A, Almutairi W, Albujaidy A, AlJuaid L, Almalki ZS, Ahmed N, Alajami HN, Aljishi HM, Alsheef M, Alajlan SA, Almutairi F, Alsirhani A, Alotaibi M, Aljaber MA, Bahammam HA, Aldandan H, Almulhim AS, Abraham I, Alamer A. Alrashed A, et al. Among authors: alfaifi m. Front Cardiovasc Med. 2022 Aug 16;9:978420. doi: 10.3389/fcvm.2022.978420. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36051287 Free PMC article.
The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study.
Aljuhani O, Korayem GB, Altebainawi AF, Alotaibi MS, Alrakban NA, Ghoneim RH, Vishwakarma R, Al Shaya AI, Al Harbi S, Gramish J, Almutairi DM, Alqannam G, Alamri FF, Alharthi AF, Alfaifi M, Al Amer A, Alenazi AA, Bin Aydan N, Alalawi M, Al Sulaiman K. Aljuhani O, et al. Among authors: alfaifi m. Saudi Pharm J. 2023 Jul;31(7):1210-1218. doi: 10.1016/j.jsps.2023.05.006. Epub 2023 May 23. Saudi Pharm J. 2023. PMID: 37256102 Free PMC article.
Research barriers in Saudi pharmacy residency training programs.
Alfayez OM, AlFaifi M, Alkhezi OS, Alahmed AA, Alalwan AA. Alfayez OM, et al. Among authors: alfaifi m. Saudi Pharm J. 2023 Dec;31(12):101842. doi: 10.1016/j.jsps.2023.101842. Epub 2023 Oct 21. Saudi Pharm J. 2023. PMID: 38028214 Free PMC article.
Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study.
Aljuhani O, Al Sulaiman K, Korayem GB, Altebainawi AF, Alshaya A, Nahari M, Alsamnan K, Alkathiri MA, Al-Dosari BS, Alenazi AA, Alsohimi S, Alnajjar LI, Alfaifi M, AlQussair N, Alanazi RM, Alhmoud MF, Alanazi NL, Alkofide H, Alenezi AM, Vishwakarma R. Aljuhani O, et al. Among authors: alfaifi m. Saudi Pharm J. 2024 May;32(5):102061. doi: 10.1016/j.jsps.2024.102061. Epub 2024 Apr 3. Saudi Pharm J. 2024. PMID: 38596319 Free PMC article.
The concomitant use of ultra short beta-blockers with vasopressors and inotropes in critically ill patients with septic shock: A systematic review and meta-analysis of randomized controlled trials.
Al Sulaiman K, Alkofide HA, AlFaifi ME, Aljohani SS, Al Harthi AF, Alqahtani RA, Alanazi AM, Nazer LH, Al Shaya AI, Aljuhani O. Al Sulaiman K, et al. Among authors: alfaifi me. Saudi Pharm J. 2024 Jun;32(6):102094. doi: 10.1016/j.jsps.2024.102094. Epub 2024 May 11. Saudi Pharm J. 2024. PMID: 38812943 Free PMC article.
When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, AlFaifi M, Nahari M, Almagthali A, Thabit AK, Alhajaji R, Alharbi R, Kahtani K, Alenazi AA, Alharbi A, Alghwainm MM, Alotaibi SM, Alghamdi YS, Alotaibi S, Alonazi SH, Almutairi JM, Vishwakarma R. Al Sulaiman K, et al. Among authors: alfaifi m. J Infect Public Health. 2023 Sep;16(9):1492-1499. doi: 10.1016/j.jiph.2023.06.011. Epub 2023 Jun 14. J Infect Public Health. 2023. PMID: 37355406 Free PMC article.
The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study.
Aljuhani O, Al Sulaiman K, B Korayem G, Alharbi A, Altebainawi AF, Aldkheel SA, Alotaibi SG, Vishwakarma R, Alshareef H, Alsohimi S, AlFaifi M, Al Shaya A, Alhaidal HA, Alsubaie RM, Alrashidi H, Albarqi KJ, Alangari DT, Alanazi RM, Altaher NM, Al-Dorzi HM. Aljuhani O, et al. Among authors: alfaifi m. Ren Fail. 2023;45(2):2268213. doi: 10.1080/0886022X.2023.2268213. Epub 2023 Oct 23. Ren Fail. 2023. PMID: 37870869 Free PMC article.
The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, Vishwakarma R, AlFaifi M, Alsohimi S, Alrayes A, Albishi S, Alqahtani R, Alalawi M, Al Sulaihim I, Alanazi TA, Alqahtani RA, Almagthali A, Jomah S, Alshlowi A, Alshammari TR, Alzahrani SS, Abdulqader MI. Al Sulaiman K, et al. Among authors: alfaifi m. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231218216. doi: 10.1177/10760296231218216. Clin Appl Thromb Hemost. 2023. PMID: 38073058 Free PMC article.
224 results